首页> 中文期刊>中国天然药物 >XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression

XingNaoJing injections protect against cerebral ischemia/reperfusion injury and alleviate blood-brain barrier disruption in rats, through an underlying mechanism of NLRP3 inflammasomes suppression

     

摘要

The aim of this study was to explore the neuroprotective effect and mechanism of XingNaoJing injections (XNJ) on cerebral ischemia injury and blood-brain barrier (BBB) disruption.Middle cerebral artery occlusion (MCAO) method was applicated to establish the model of cerebral ischemia/reperfusion (I/R) injury in rats.BBB permeability after I/R injury was assessed with the leaking amount of Evans Blue and the expression of occludin and ZO-1.The expression of NOD-like receptor family,pyrin domain containing (NLRP3) was checked to explore the inhibition of inflammation by XNJ.The results showed that XNJ could significantly increase the survival percent,decrease the infarct area and ameliorate neurological deficits and brain damage after I/R injury.Leaking amount of Evans Blue was reduced by XNJ,and the expression of tight junction protein,occludin and ZO-1 was also up-regulated by XNJ,which showed a role of protection on BBB disruption.The expression of NLRP3 was inhibited after exposure of XNJ,which was associated with inhibition of the inflammatory response.In summary,XNJ could suppress NLRP3 inflammasomes and improve BBB disruption and brain damage in rats after cerebral I/R injury,which provided a beneficial insight to further explore XNJ.

著录项

  • 来源
    《中国天然药物》|2019年第7期|498-505|共8页
  • 作者单位

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

    Department of Pharmacy, the First Hospital of Jilin University, Changchun 130021, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 实验药理学;
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号